| A Trial of HBM9378 in Healthy Chinese Subjects (NCT05790694) | Harbour BioMed (Guangzhou) Co. Ltd. | 2022-09-23 |
| Evaluate the Safety of HBM9161 (HL161) Subcutaneous Injection in Patients With Generalized Myasthenia Gravis (NCT05332210) | Harbour BioMed (Guangzhou) Co. Ltd. | 2022-06-30 |
| HBM4003 Combine With Toripalimab in Patients With Advanced NEN and Other Solid Tumors Study (NCT05167071) | Harbour BioMed (Guangzhou) Co. Ltd. | 2021-12-28 |
| A Study to Evaluate Safety, Tolerability, PK/PD and Preliminary Efficacy of HBM4003 Combine With Toripalimab in Patients With Advanced HCC and Other Solid Tumors (NCT05149027) | Harbour BioMed (Guangzhou) Co. Ltd. | 2021-12-20 |
| Evaluate the Efficacy and Safety of HBM9161(HL161)Subcutaneous Injection in Patients With Generalized MG Patients (NCT05039190) | Harbour BioMed (Guangzhou) Co. Ltd. | 2021-09-25 |
| A Study to Evaluate the Efficacy and Safety of HBM9161 on Moderate to Severe Thyroid Eye Disease (NCT05015127) | Harbour BioMed (Guangzhou) Co. Ltd. | 2021-09-22 |
| A Study to Evaluate Safety, Tolerability, PK/PD and Preliminary Efficacy of HBM4003 Combined With Anti-PD-1 Antibody (NCT04866485) | Harbour BioMed (Guangzhou) Co. Ltd. | 2021-06-14 |
| Study Investigating Safety,Tolerability,Pharmacokinetics and Antitumor Activities of HBM4003 Combine With Toripalimab (NCT04727164) | Harbour BioMed (Guangzhou) Co. Ltd. | 2021-02-28 |
| A Study Evaluating HBM9036 Efficacy and Safety on Moderate to Severe Dry Eye (NCT04633213) | Harbour BioMed (Guangzhou) Co. Ltd. | 2021-02-25 |
| A Clinical Study on the Efficacy and Safety of HBM9161 in Patients With ITP (NCT04428255) | Harbour BioMed (Guangzhou) Co. Ltd. | 2020-07-24 |
| A Study to Evaluate the Efficacy, Safety and PD and PK of HBM9161 in MG Patients (NCT04346888) | Harbour BioMed (Guangzhou) Co. Ltd. | 2020-07-23 |
| A Study of HBM9161 in NMOSD Patients (NCT04227470) | Harbour BioMed (Guangzhou) Co. Ltd. | 2020-03-31 |
| A Phase I Study Evaluating the Safety, Tolerability, PK and PD in Healthy Chinese Volunteers (NCT03971916) | Harbour BioMed (Guangzhou) Co. Ltd. | 2019-06-03 |
| A Study Evaluating the Efficacy and Safety on Moderate to Severe Dry Eye (NCT04092907) | Harbour BioMed (Guangzhou) Co. Ltd. | 2019-03-22 |